Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies

The Journal of Clinical Investigation
O E BroddeH R Zerkowski

Abstract

The M1 muscarinic receptor antagonist pirenzepine in low doses decreases resting heart rate; this effect declines with age (Poller, U., G. Nedelka, J. Radke, K. Pönicke, and O.-E. Brodde. 1997. J. Am. Coll. Cardiol. 29:187-193). To study possible mechanisms underlying this effect, we assessed (a) in six young (26 yr old) and six older volunteers (61 yr old), pirenzepine effects (0.32 and 0.64 mg intravenous [i.v.] bolus) on isoprenaline-induced heart rate increases; (b) in five heart transplant recipients, pirenzepine effects (0.05-10 mg i.v. bolus) on resting heart rate in the recipient's native and transplanted sinus nodes; and (c) in right atria from 39 patients of different ages (5 d-76 yr) undergoing open heart surgery, M2 muscarinic receptor density (by [3H]N-methyl-scopolamine binding) and adenylyl cyclase activity. (a) Pirenzepine at both doses decreased heart rate in young volunteers significantly more than in older volunteers; (b) pirenzepine (< 1 mg) decreased resting heart rate in the recipient's native but not transplanted sinus node; and (c) M2 receptor density and carbachol-induced inhibition of forskolin-stimulated adenylyl cyclase activity decreased significantly with the age of the patients. We conclude that p...Continue Reading

References

Aug 1, 1988·Naunyn-Schmiedeberg's Archives of Pharmacology·H F Pitschner, A Wellstein
Jan 1, 1988·Life Sciences·E GiraldoF Sanchez de La Cuesta
Jul 1, 1988·Naunyn-Schmiedeberg's Archives of Pharmacology·A Wellstein, H F Pitschner
Nov 1, 1971·Circulation Research·M N Levy
Apr 1, 1974·Analytical Biochemistry·Y SalomonM Rodbell
Sep 1, 1984·British Journal of Clinical Pharmacology·J M Arnold, D G McDevitt
Aug 1, 1983·The American Journal of Medicine·M A PfeiferJ B Halter
Mar 1, 1994·Journal of the American College of Cardiology·J KoglinE Erdmann
Oct 1, 1993·Journal of the American College of Cardiology·M R Bristow
Feb 1, 1996·Pharmacology & Toxicology·R M Eglen, N Watson
Jan 1, 1997·Journal of the American College of Cardiology·U PollerO E Brodde
Jul 1, 1997·Naunyn-Schmiedeberg's Archives of Pharmacology·U PollerO E Brodde

❮ Previous
Next ❯

Citations

Feb 9, 2010·World Journal of Urology·Maya SchiffersUlrich Mehnert
Dec 23, 2009·Bulletin of Experimental Biology and Medicine·T A AnikinaA A Zverev
Mar 14, 2008·Neuromolecular Medicine·David M Kaye, Murray D Esler
Oct 31, 1998·European Journal of Pharmacology·C GiesslerO E Brodde
Aug 12, 1999·European Journal of Pharmacology·C GiesslerO E Brodde
Aug 10, 2000·Journal of the American College of Cardiology·S DheinO E Brodde
May 3, 2002·Journal of the American College of Cardiology·Padmini Kaushal, J Andrew Taylor
Oct 24, 2002·Journal of the American College of Cardiology·Kirsten LeineweberOtto Erich Brodde
Jun 12, 2003·Journal of the American College of Cardiology·John R StrattonKen Madden
Oct 18, 2003·Journal of the American College of Cardiology·Kirsten LeineweberOtto Erich Brodde
Jul 9, 2002·Clinical and Experimental Pharmacology & Physiology·Fumio KurogouchiShigetoshi Chiba
Jun 24, 2008·Experimental Aging Research·Silvia Del RyEttore Bergamini
May 24, 2001·American Journal of Respiratory and Critical Care Medicine·L S OnR W Costello
Jun 27, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Hirofumi TasakiKatsusuke Yano
Dec 13, 2000·Journal of Molecular and Cellular Cardiology·T SeyfarthO E Brodde
Jul 4, 2002·The Journal of Physiology·Christopher A DeSouzaBrian L Stauffer
Jan 27, 2009·European Journal of Pharmacology·Alexander McNamaraSharath S Hegde
Apr 15, 2015·Journal of Molecular and Cellular Cardiology·Edward G Lakatta
Nov 13, 2007·The American Journal of Geriatric Pharmacotherapy·Mark W Bowie, Patricia W Slattum
Jul 23, 2003·British Journal of Pharmacology·Sophie BuysJean-Michel Senard
May 21, 2011·British Journal of Clinical Pharmacology·Karl-Erik AnderssonBrian Olshansky
Oct 7, 2004·European Journal of Pharmacology·Otto-Erich Brodde, Kirsten Leineweber
Oct 13, 2006·Biological Psychology·Christopher M MasiJohn T Cacioppo
Sep 1, 2001·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·S DheinO E Brodde
Dec 21, 2010·European Urology·Karl-Erik Andersson
Feb 29, 2008·Autonomic Neuroscience : Basic & Clinical·Richard P SloanTeresa Seeman
Mar 7, 2008·Autonomic Neuroscience : Basic & Clinical·Kichang LeeJ Andrew Taylor
Jun 15, 2010·Neurobiology of Aging·Carine C Callegaro, J Andrew Taylor
Oct 31, 2006·Biochimica Et Biophysica Acta·Regina AlemanyValentina Ruiz-Gutierrez
Aug 21, 2002·The Journal of Urology·Martin C MichelMark Goepel
Jun 22, 2016·Antimicrobial Agents and Chemotherapy·S Ken Tanaka, Stephen Villano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.